Cargando…
Metabolic syndrome and breast cancer survivors: a follow-up analysis after completion of chemotherapy
BACKGROUND: We previously reported that (neo)adjuvant chemotherapy adversely altered metabolic syndrome (MetS) components, body composition, and related biomarkers after a 12 to 18-week chemotherapy treatment course in women. Here, we sought to determine whether these measures worsened within 4–5 ye...
Autores principales: | Dieli-Conwright, Christina M., Wong, Louise, Waliany, Sarah, Mortimer, Joanne E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895575/ https://www.ncbi.nlm.nih.gov/pubmed/35241143 http://dx.doi.org/10.1186/s13098-022-00807-y |
Ejemplares similares
-
An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy
por: Dieli‐Conwright, Christina M., et al.
Publicado: (2016) -
Objective physical and mental markers of self‐reported fatigue in women undergoing (neo)adjuvant chemotherapy for early‐stage breast cancer
por: Mortimer, Joanne E., et al.
Publicado: (2017) -
Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: rationale, design, and methods
por: Dieli-Conwright, Christina M, et al.
Publicado: (2014) -
Effects of high-intensity interval training on vascular function in breast cancer survivors undergoing anthracycline chemotherapy: design of a pilot study
por: Lee, Kyuwan, et al.
Publicado: (2018) -
The Impact of Obesity on Breast Cancer Diagnosis and Treatment
por: Lee, Kyuwan, et al.
Publicado: (2019)